Human papilloma virus 16 E6 oncoprotein associated with p53 inactivation in colorectal cancer

Tan Hsia Chen, Chi Chou Huang, Kun Tu Yeh, Shu Hau Chang, Shih Wen Chang, Wen Wei Sung, Ya Wen Cheng, Huei Lee

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

AIM: To investigate the association between human papilloma virus (HPV) infection and colorectal cancer. METHODS: Sixty-nine patients with pathologically confirmed primary colorectal cancer including 6 stage I, 24 stage II, 21 stage III, and 18 stage IV patients were enrolled in this study to investigate whether HPV 16 could be involved in colorectal tumorigenesis. Nested- polymerase chain reaction (nested-PCR) was used to detect HPV16 DNA in colorectal tumor tissues and further confirmed by in situ hybridization (ISH). In addition, immunohistochemistry analysis was performed to examine the E6 oncoprotein in colorectal tumors. To verify whether E6 could inactivate the p53 transcriptional function, the levels of p21 and Mdm2 mRNA expression were evaluated by real-time reverse transcription (RT)-PCR. RESULTS: Of the 69 colorectal tumors, HPV16 DNA was detected in 11 (16%) by nested-PCR, and HPV16 DNA was present in 8 of the 11 (73%) tumors which was confirmed by ISH. The presence of HPV16 DNA in colorectal tumors was not associated with patients' clinical parameters including age, gender, smoking status, tumor site; however, HPV16 infection was more common in stage I patients than in late-stages patients (II, III and IV). We next asked whether HPV16 infection could be linked with colorectal cancer development. Immunohistochemical data indicated that 8 of the 11 HPV16 DNA-positive tumors had E6 oncoprotein expression. Moreover, we also observed that the adjacent normal tissues including endothelial cells, lymphocytes, fibroblasts, and gland cells in E6-positive tumors had E6 oncoprotein expression. In addition, 3 of the 4 (75%) E6-positive tumors carrying p53 wild-type had negative immunostaining, but one tumor had less p53 immunostaining. We further examined whether E6-positive and/or p53 mutated tumors reduce p53 transcriptional activity. Real-time RT-PCR analysis indicated that p21 and mdm2 mRNA expression levels in E6/p53-wildtype tumors were significantly lower than in their adjacent normal tissues; as expected, E6-positive/p53-mutated tumors had lower p21 and mdm2 mRNA expression levels compared with their adjacent normal tissues. These results clearly indicate that the E6 oncoprotein expressed in p53 wildtype tumors may reduce p21 and mdm2 expression via p53 inactivation. CONCLUSION: These results suggest that HPV16 infection may be involved in a subset of colorectal cancer, and we suggest that the transmission of HPV to the colon and rectum might occur through peripheral blood lymphocytes.

Original languageEnglish
Pages (from-to)4051-4058
Number of pages8
JournalWorld Journal of Gastroenterology
Volume18
Issue number30
DOIs
Publication statusPublished - 2012

Fingerprint

Papillomaviridae
Oncogene Proteins
Colorectal Neoplasms
Neoplasms
DNA
Polymerase Chain Reaction
Messenger RNA
Reverse Transcription
In Situ Hybridization
Infection
Lymphocytes
Virus Diseases
Rectum

Keywords

  • Blood lymphocytes
  • Colorectal cancer
  • Human papilloma virus
  • P21
  • P53

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Chen, T. H., Huang, C. C., Yeh, K. T., Chang, S. H., Chang, S. W., Sung, W. W., ... Lee, H. (2012). Human papilloma virus 16 E6 oncoprotein associated with p53 inactivation in colorectal cancer. World Journal of Gastroenterology, 18(30), 4051-4058. https://doi.org/10.3748/wjg.v18.i30.4051

Human papilloma virus 16 E6 oncoprotein associated with p53 inactivation in colorectal cancer. / Chen, Tan Hsia; Huang, Chi Chou; Yeh, Kun Tu; Chang, Shu Hau; Chang, Shih Wen; Sung, Wen Wei; Cheng, Ya Wen; Lee, Huei.

In: World Journal of Gastroenterology, Vol. 18, No. 30, 2012, p. 4051-4058.

Research output: Contribution to journalArticle

Chen, TH, Huang, CC, Yeh, KT, Chang, SH, Chang, SW, Sung, WW, Cheng, YW & Lee, H 2012, 'Human papilloma virus 16 E6 oncoprotein associated with p53 inactivation in colorectal cancer', World Journal of Gastroenterology, vol. 18, no. 30, pp. 4051-4058. https://doi.org/10.3748/wjg.v18.i30.4051
Chen, Tan Hsia ; Huang, Chi Chou ; Yeh, Kun Tu ; Chang, Shu Hau ; Chang, Shih Wen ; Sung, Wen Wei ; Cheng, Ya Wen ; Lee, Huei. / Human papilloma virus 16 E6 oncoprotein associated with p53 inactivation in colorectal cancer. In: World Journal of Gastroenterology. 2012 ; Vol. 18, No. 30. pp. 4051-4058.
@article{2733f7435b7947afa833a56f2d5efa4a,
title = "Human papilloma virus 16 E6 oncoprotein associated with p53 inactivation in colorectal cancer",
abstract = "AIM: To investigate the association between human papilloma virus (HPV) infection and colorectal cancer. METHODS: Sixty-nine patients with pathologically confirmed primary colorectal cancer including 6 stage I, 24 stage II, 21 stage III, and 18 stage IV patients were enrolled in this study to investigate whether HPV 16 could be involved in colorectal tumorigenesis. Nested- polymerase chain reaction (nested-PCR) was used to detect HPV16 DNA in colorectal tumor tissues and further confirmed by in situ hybridization (ISH). In addition, immunohistochemistry analysis was performed to examine the E6 oncoprotein in colorectal tumors. To verify whether E6 could inactivate the p53 transcriptional function, the levels of p21 and Mdm2 mRNA expression were evaluated by real-time reverse transcription (RT)-PCR. RESULTS: Of the 69 colorectal tumors, HPV16 DNA was detected in 11 (16{\%}) by nested-PCR, and HPV16 DNA was present in 8 of the 11 (73{\%}) tumors which was confirmed by ISH. The presence of HPV16 DNA in colorectal tumors was not associated with patients' clinical parameters including age, gender, smoking status, tumor site; however, HPV16 infection was more common in stage I patients than in late-stages patients (II, III and IV). We next asked whether HPV16 infection could be linked with colorectal cancer development. Immunohistochemical data indicated that 8 of the 11 HPV16 DNA-positive tumors had E6 oncoprotein expression. Moreover, we also observed that the adjacent normal tissues including endothelial cells, lymphocytes, fibroblasts, and gland cells in E6-positive tumors had E6 oncoprotein expression. In addition, 3 of the 4 (75{\%}) E6-positive tumors carrying p53 wild-type had negative immunostaining, but one tumor had less p53 immunostaining. We further examined whether E6-positive and/or p53 mutated tumors reduce p53 transcriptional activity. Real-time RT-PCR analysis indicated that p21 and mdm2 mRNA expression levels in E6/p53-wildtype tumors were significantly lower than in their adjacent normal tissues; as expected, E6-positive/p53-mutated tumors had lower p21 and mdm2 mRNA expression levels compared with their adjacent normal tissues. These results clearly indicate that the E6 oncoprotein expressed in p53 wildtype tumors may reduce p21 and mdm2 expression via p53 inactivation. CONCLUSION: These results suggest that HPV16 infection may be involved in a subset of colorectal cancer, and we suggest that the transmission of HPV to the colon and rectum might occur through peripheral blood lymphocytes.",
keywords = "Blood lymphocytes, Colorectal cancer, Human papilloma virus, P21, P53",
author = "Chen, {Tan Hsia} and Huang, {Chi Chou} and Yeh, {Kun Tu} and Chang, {Shu Hau} and Chang, {Shih Wen} and Sung, {Wen Wei} and Cheng, {Ya Wen} and Huei Lee",
year = "2012",
doi = "10.3748/wjg.v18.i30.4051",
language = "English",
volume = "18",
pages = "4051--4058",
journal = "World Journal of Gastroenterology",
issn = "1007-9327",
publisher = "WJG Press",
number = "30",

}

TY - JOUR

T1 - Human papilloma virus 16 E6 oncoprotein associated with p53 inactivation in colorectal cancer

AU - Chen, Tan Hsia

AU - Huang, Chi Chou

AU - Yeh, Kun Tu

AU - Chang, Shu Hau

AU - Chang, Shih Wen

AU - Sung, Wen Wei

AU - Cheng, Ya Wen

AU - Lee, Huei

PY - 2012

Y1 - 2012

N2 - AIM: To investigate the association between human papilloma virus (HPV) infection and colorectal cancer. METHODS: Sixty-nine patients with pathologically confirmed primary colorectal cancer including 6 stage I, 24 stage II, 21 stage III, and 18 stage IV patients were enrolled in this study to investigate whether HPV 16 could be involved in colorectal tumorigenesis. Nested- polymerase chain reaction (nested-PCR) was used to detect HPV16 DNA in colorectal tumor tissues and further confirmed by in situ hybridization (ISH). In addition, immunohistochemistry analysis was performed to examine the E6 oncoprotein in colorectal tumors. To verify whether E6 could inactivate the p53 transcriptional function, the levels of p21 and Mdm2 mRNA expression were evaluated by real-time reverse transcription (RT)-PCR. RESULTS: Of the 69 colorectal tumors, HPV16 DNA was detected in 11 (16%) by nested-PCR, and HPV16 DNA was present in 8 of the 11 (73%) tumors which was confirmed by ISH. The presence of HPV16 DNA in colorectal tumors was not associated with patients' clinical parameters including age, gender, smoking status, tumor site; however, HPV16 infection was more common in stage I patients than in late-stages patients (II, III and IV). We next asked whether HPV16 infection could be linked with colorectal cancer development. Immunohistochemical data indicated that 8 of the 11 HPV16 DNA-positive tumors had E6 oncoprotein expression. Moreover, we also observed that the adjacent normal tissues including endothelial cells, lymphocytes, fibroblasts, and gland cells in E6-positive tumors had E6 oncoprotein expression. In addition, 3 of the 4 (75%) E6-positive tumors carrying p53 wild-type had negative immunostaining, but one tumor had less p53 immunostaining. We further examined whether E6-positive and/or p53 mutated tumors reduce p53 transcriptional activity. Real-time RT-PCR analysis indicated that p21 and mdm2 mRNA expression levels in E6/p53-wildtype tumors were significantly lower than in their adjacent normal tissues; as expected, E6-positive/p53-mutated tumors had lower p21 and mdm2 mRNA expression levels compared with their adjacent normal tissues. These results clearly indicate that the E6 oncoprotein expressed in p53 wildtype tumors may reduce p21 and mdm2 expression via p53 inactivation. CONCLUSION: These results suggest that HPV16 infection may be involved in a subset of colorectal cancer, and we suggest that the transmission of HPV to the colon and rectum might occur through peripheral blood lymphocytes.

AB - AIM: To investigate the association between human papilloma virus (HPV) infection and colorectal cancer. METHODS: Sixty-nine patients with pathologically confirmed primary colorectal cancer including 6 stage I, 24 stage II, 21 stage III, and 18 stage IV patients were enrolled in this study to investigate whether HPV 16 could be involved in colorectal tumorigenesis. Nested- polymerase chain reaction (nested-PCR) was used to detect HPV16 DNA in colorectal tumor tissues and further confirmed by in situ hybridization (ISH). In addition, immunohistochemistry analysis was performed to examine the E6 oncoprotein in colorectal tumors. To verify whether E6 could inactivate the p53 transcriptional function, the levels of p21 and Mdm2 mRNA expression were evaluated by real-time reverse transcription (RT)-PCR. RESULTS: Of the 69 colorectal tumors, HPV16 DNA was detected in 11 (16%) by nested-PCR, and HPV16 DNA was present in 8 of the 11 (73%) tumors which was confirmed by ISH. The presence of HPV16 DNA in colorectal tumors was not associated with patients' clinical parameters including age, gender, smoking status, tumor site; however, HPV16 infection was more common in stage I patients than in late-stages patients (II, III and IV). We next asked whether HPV16 infection could be linked with colorectal cancer development. Immunohistochemical data indicated that 8 of the 11 HPV16 DNA-positive tumors had E6 oncoprotein expression. Moreover, we also observed that the adjacent normal tissues including endothelial cells, lymphocytes, fibroblasts, and gland cells in E6-positive tumors had E6 oncoprotein expression. In addition, 3 of the 4 (75%) E6-positive tumors carrying p53 wild-type had negative immunostaining, but one tumor had less p53 immunostaining. We further examined whether E6-positive and/or p53 mutated tumors reduce p53 transcriptional activity. Real-time RT-PCR analysis indicated that p21 and mdm2 mRNA expression levels in E6/p53-wildtype tumors were significantly lower than in their adjacent normal tissues; as expected, E6-positive/p53-mutated tumors had lower p21 and mdm2 mRNA expression levels compared with their adjacent normal tissues. These results clearly indicate that the E6 oncoprotein expressed in p53 wildtype tumors may reduce p21 and mdm2 expression via p53 inactivation. CONCLUSION: These results suggest that HPV16 infection may be involved in a subset of colorectal cancer, and we suggest that the transmission of HPV to the colon and rectum might occur through peripheral blood lymphocytes.

KW - Blood lymphocytes

KW - Colorectal cancer

KW - Human papilloma virus

KW - P21

KW - P53

UR - http://www.scopus.com/inward/record.url?scp=84871502553&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871502553&partnerID=8YFLogxK

U2 - 10.3748/wjg.v18.i30.4051

DO - 10.3748/wjg.v18.i30.4051

M3 - Article

VL - 18

SP - 4051

EP - 4058

JO - World Journal of Gastroenterology

JF - World Journal of Gastroenterology

SN - 1007-9327

IS - 30

ER -